| __timestamp | Protagonist Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 22223073 |
| Thursday, January 1, 2015 | 11831000 | 6966842 |
| Friday, January 1, 2016 | 25705000 | 9000499 |
| Sunday, January 1, 2017 | 46181000 | 13741186 |
| Monday, January 1, 2018 | 59497000 | 19040000 |
| Tuesday, January 1, 2019 | 65003000 | 23559000 |
| Wednesday, January 1, 2020 | 74506000 | 31931000 |
| Friday, January 1, 2021 | 126006000 | 44981000 |
| Saturday, January 1, 2022 | 126215000 | 54234000 |
| Sunday, January 1, 2023 | 120161000 | 63806000 |
Data in motion
In the dynamic world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Protagonist Therapeutics, Inc. and Viking Therapeutics, Inc. have been at the forefront of this evolution. From 2014 to 2023, Protagonist Therapeutics has consistently outpaced Viking Therapeutics in R&D spending, with an average annual increase of approximately 15%. By 2023, Protagonist's R&D expenses surged to nearly double that of Viking's, highlighting their aggressive pursuit of groundbreaking therapies.
Viking Therapeutics, while trailing, has shown a steady growth trajectory, with a notable 187% increase in R&D expenses from 2014 to 2023. This commitment underscores their strategic focus on expanding their therapeutic pipeline. As these companies continue to invest in R&D, they not only drive their own growth but also contribute significantly to the advancement of medical science.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Viking Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending